BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26177578)

  • 1. Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation.
    Jarrott B; Williams SJ
    Neurochem Res; 2016 Mar; 41(3):523-33. PubMed ID: 26177578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Changes in the Activation and Regulation of Microglia.
    Cornejo F; von Bernhardi R
    Adv Exp Med Biol; 2016; 949():205-226. PubMed ID: 27714691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic approaches to inflammation in neurodegenerative disease.
    Klegeris A; McGeer EG; McGeer PL
    Curr Opin Neurol; 2007 Jun; 20(3):351-7. PubMed ID: 17495632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation in central nervous system injury.
    Allan SM; Rothwell NJ
    Philos Trans R Soc Lond B Biol Sci; 2003 Oct; 358(1438):1669-77. PubMed ID: 14561325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The kynurenine pathway in neurodegenerative diseases: mechanistic and therapeutic considerations.
    Tan L; Yu JT; Tan L
    J Neurol Sci; 2012 Dec; 323(1-2):1-8. PubMed ID: 22939820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic expression of low levels of tumor necrosis factor-alpha in the substantia nigra elicits progressive neurodegeneration, delayed motor symptoms and microglia/macrophage activation.
    De Lella Ezcurra AL; Chertoff M; Ferrari C; Graciarena M; Pitossi F
    Neurobiol Dis; 2010 Mar; 37(3):630-40. PubMed ID: 19969084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?
    Marchetti B; Abbracchio MP
    Trends Pharmacol Sci; 2005 Oct; 26(10):517-25. PubMed ID: 16126283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple mechanisms that prevent excessive brain inflammation.
    Yang MS; Min KJ; Joe E
    J Neurosci Res; 2007 Aug; 85(11):2298-305. PubMed ID: 17348044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia Purinoceptor P2Y6: An Emerging Therapeutic Target in CNS Diseases.
    Anwar S; Pons V; Rivest S
    Cells; 2020 Jul; 9(7):. PubMed ID: 32630251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glial cell reactions in neurodegenerative diseases: pathophysiology and therapeutic interventions.
    McGeer PL; McGeer EG
    Alzheimer Dis Assoc Disord; 1998; 12 Suppl 2():S1-6. PubMed ID: 9769023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial priming and enhanced reactivity to secondary insult in aging, and traumatic CNS injury, and neurodegenerative disease.
    Norden DM; Muccigrosso MM; Godbout JP
    Neuropharmacology; 2015 Sep; 96(Pt A):29-41. PubMed ID: 25445485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes.
    Blasko I; Stampfer-Kountchev M; Robatscher P; Veerhuis R; Eikelenboom P; Grubeck-Loebenstein B
    Aging Cell; 2004 Aug; 3(4):169-76. PubMed ID: 15268750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils.
    Bulgarelli I; Tamiazzo L; Bresciani E; Rapetti D; Caporali S; Lattuada D; Locatelli V; Torsello A
    J Neurosci Res; 2009 Sep; 87(12):2718-27. PubMed ID: 19382238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms.
    Choi DY; Choi H
    Arch Pharm Res; 2015 Feb; 38(2):139-70. PubMed ID: 25348867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microglia: activation in acute and chronic inflammatory states and in response to cardiovascular dysfunction.
    Badoer E
    Int J Biochem Cell Biol; 2010 Oct; 42(10):1580-5. PubMed ID: 20638485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local neuroinflammation and the progression of Alzheimer's disease.
    McGeer PL; McGeer EG
    J Neurovirol; 2002 Dec; 8(6):529-38. PubMed ID: 12476347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory processes in Alzheimer's disease.
    McGeer EG; McGeer PL
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):741-9. PubMed ID: 12921904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.
    Członkowska A; Kurkowska-Jastrzebska I; Członkowski A; Peter D; Stefano GB
    Med Sci Monit; 2002 Aug; 8(8):RA165-77. PubMed ID: 12165754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.